HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BMS188797

Also Known As:
BMS-188797
Networked: 7 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cohen, Marvin B: 2 articles (01/2006 - 05/2005)
2. Dellaportas, Anne M: 2 articles (01/2006 - 05/2005)
3. Fishman, Mayer N: 2 articles (01/2006 - 05/2005)
4. Garrett, Christopher R: 2 articles (01/2006 - 05/2005)
5. Lush, Richard M: 2 articles (01/2006 - 05/2005)
6. Mahany, J Joseph: 2 articles (01/2006 - 05/2005)
7. Sullivan, Daniel M: 2 articles (01/2006 - 05/2005)
8. Gollerkeri, Ashwin: 2 articles (05/2005 - 11/2003)
9. Bayes, M: 1 article (09/2006)
10. Prous, J R: 1 article (09/2006)

Related Diseases

1. Neoplasms (Cancer)
2. Febrile Neutropenia
3. Hepatitis C
09/01/2006 - "The data in the following tables have been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity, the drug discovery and development portal, http://integrity.prous.com This issue focuses on the following selection of drugs: A-007, A6, adalimumab, adenosine triphosphate, alefacept, alemtuzumab, AllerVax Ragweed, amphora, anakinra, angiotensin-(1-7), anidulafungin, apomine, aripiprazole, atomoxetine hydrochloride, avanafil; BAL-8557, becatecarin, bevacizumab, biphasic insulin aspart, BMS-188797, bortezomib, bosentan, botulinum toxin type B, brivudine; Calcipotriol/betamethasone dipropionate, caspofungin acetate, catumaxomab, certolizumab pegol, cetuximab, CG-0070, ciclesonide, cinacalcet hydrochloride, clindamycin phosphate/benzoyl peroxide, cryptophycin 52, Cypher; Dabigatran etexilate, darapladib, darbepoetin alfa, decitabine, deferasirox, desloratadine, dexanabinol, dextromethorphan/quinidine sulfate, DMF, drotrecogin alfa (activated), duloxetine hydrochloride; E-7010, edaravone, efalizumab, emtricitabine, entecavir, eplerenone, erlotinib hydrochloride, escitalopram oxalate, estradiol valerate/dienogest, eszopiclone, exenatide, ezetimibe; Fondaparinux sodium, fulvestrant; Gefitinib, gestodene, GYKI-16084; Hyaluronic acid, hydralazine hydrochloride/isosorbide dinitrate; Imatinib mesylate, indiplon, insulin glargine; Juzen-taiho-to; Lamivudine/zidovudine/abacavir sulfate, L-arginine hydrochloride, lasofoxifene tartrate, L-BLP-25, lenalidomide, levocetirizine, levodopa/carbidopa/entacapone, lexatumumab, lidocaine/prilocaine, lubiprostone, lumiracoxib; MAb-14.18, mitoquidone; Natalizumab, neridronic acid, neuradiab; Olpadronic acid sodium salt, omalizumab; p53-DC vaccine, parathyroid hormone (human recombinant), peginterferon alfa-2a, peginterferon alfa-2b, pemetrexed disodium, perifosine, pimecrolimus, prasterone, prasugrel, PRO-2000, Pseudostat; R24, rasburicase, RHAMM R3 peptide, rilonacept, rosuvastatin calcium, rotavirus vaccine, rufinamide; Sabarubicin hydrochloride, SHL-749, sirolimus-eluting stent, SLx-2101, sodium butyrate, sorafenib, SU-6668; TachoSil, tadalafil, taxus, tegaserod maleate, telbivudine, tenofovir disoproxil fumarate, teriparatide, tetramethylpyrazine, teverelix, tiotropium bromide, tipifarnib, tirapazamine, tolvaptan, TransvaxTM hepatitis C vaccine, treprostinil sodium; Valganciclovir hydrochloride, valsartan/amlodipine, vandetanib, vardenafil hydrochloride hydrate, vatalanib succinate, veglin, voriconazole; Yttrium 90 (90Y) ibritumomab tiuxetan; Zileuton, zotarolimus, zotarolimus-eluting stent."
4. Sarcoma (Soft Tissue Sarcoma)
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. taxane
2. Voriconazole (Vfend)
3. Biphasic Insulins
4. Interleukin 1 Receptor Antagonist Protein (Anakinra)
5. Rotavirus Vaccines
6. Butyric Acid (Butanoic Acid)
7. Sirolimus (Rapamycin)
8. Succinic Acid (Succinate)
9. Teriparatide (Parathar)
10. Lamivudine (Epivir)

Related Therapies and Procedures

1. Stents
2. Radiotherapy